Caplehorn J R, Dalton M S, Cluff M C, Petrenas A M
Department of Public Health, University of Sydney, NSW, Australia.
Addiction. 1994 Feb;89(2):203-9. doi: 10.1111/j.1360-0443.1994.tb00879.x.
A long-term follow-up was made of a cohort of 307 heroin addicts admitted into a high-dose, Australian methadone maintenance programme in the early 1970s. Using data from clinic records, official death records and methadone treatment histories, it was found that subjects were nearly three times as likely to die outside of methadone maintenance as in it (95% CI RR 1.45 to 5.61). Data were further analyzed using Cox regression to investigate the association of maximum daily methadone dose and a change in clinic policy with retention in maintenance treatment. It is estimated that subjects given a maximum daily dose of 80 mg were nearly twice as likely to be discharged during the first three years of maintenance as those given 120 mg (95% CI RR 1.3 to 2.2). The estimated median time in maintenance for subjects given a maximum dose of 120 mg was 1150 days while for 80 mg it was 660 days. It is further estimated that the change in clinic policy from abstinence to indefinite maintenance reduced to one-third subjects' risk of leaving after three years' of treatment (95% CI RR 0.19 to 0.54). It is concluded that, in order to minimize heroin addicts' risk of death, they should be offered indefinite, high-dose methadone maintenance.
对20世纪70年代初进入澳大利亚一项高剂量美沙酮维持治疗项目的307名海洛因成瘾者进行了长期随访。利用诊所记录、官方死亡记录和美沙酮治疗史的数据发现,接受美沙酮维持治疗的患者死亡可能性几乎是未接受该治疗患者的三倍(95%置信区间相对危险度为1.45至5.61)。使用Cox回归进一步分析数据,以研究美沙酮最大日剂量和诊所政策变化与维持治疗留存率之间的关联。据估计,最大日剂量为80毫克的患者在维持治疗的头三年中出院的可能性几乎是最大日剂量为120毫克患者的两倍(95%置信区间相对危险度为1.3至2.2)。最大剂量为120毫克的患者维持治疗的估计中位时间为1150天,而最大剂量为80毫克的患者为660天。进一步估计,诊所政策从禁欲改为无限期维持治疗后,治疗三年后患者离开治疗的风险降低至三分之一(95%置信区间相对危险度为0.19至0.54)。研究得出结论,为了将海洛因成瘾者的死亡风险降至最低,应提供无限期的高剂量美沙酮维持治疗。